ArticleFrontiers in microbiology2022

Antisense oligonucleotides targeting ORF1b block replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Sophie Dhorne-Pollet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.